Amylyx Pharmaceuticals, Inc. (AMLX)

34.12 +0.16 (+0.49%) USD  |  NASDAQ  |  Sep 04, 16:00
34.12 0.00 (0.00%) After-Hours: 20:00
More

Amylyx Pharmaceuticals Cash and Short Term Investments (Annual) : 316.98M for Dec. 31, 2025

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for AMLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2019. Start Trial.
Date Value
December 31, 2025 316.98M
December 31, 2024 176.50M
December 31, 2023 371.36M
December 31, 2022 346.94M
Date Value
December 31, 2021 96.12M
December 31, 2020 12.88M
December 31, 2019 3.091M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Pfizer Inc. 13.60B
Eli Lilly & Co. 7.268B
Merck & Co., Inc. 14.69B
EyePoint, Inc. 306.09M
Bristol Myers Squibb Co. 10.67B